Bonton Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.28 M
- Company Age 25 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.80 M
- Satisfied Charges ₹ 0.20 M
About Bonton Pharmaceuticals
Bonton Pharmaceuticals Private Limited (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 October 1999 and has a history of 25 years and three months. Its registered office is in Gwalior, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.28 M.
The company currently has active open charges totaling ₹0.80 M. The company has closed loans amounting to ₹0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Aditya Singh and Renu Singh serve as directors at the Company.
Company Details
-
Location
Gwalior, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85120MP1999PTC013810
-
Company No.
013810
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Oct 1999
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Bonton Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aditya Singh
|
Director | 21-Oct-1999 | Current |
|
Renu Singh
|
Director | 21-Oct-1999 | Current |
Financial Performance of Bonton Pharmaceuticals.
Bonton Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bonton Pharmaceuticals?
Unlock access to Bonton Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0.80 M
₹0.20 M
Charges Breakdown by Lending Institutions
- Others : 0.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Apr 2018 | Others | ₹0.80 M | Open |
| 01 Jun 2001 | Dena Bank | ₹0.20 M | Satisfied |
How Many Employees Work at Bonton Pharmaceuticals?
Unlock and access historical data on people associated with Bonton Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bonton Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bonton Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
